Chemicals that modulate stem cell differentiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 21, 2008, Pages 7467-7471

  Hwang, Ki Chul ^a   Kim, Ji Young ^a   Chang, Woochul ^a   Kim, Dae Sung ^a   Lim, Soyeon ^a   Kang, Sang Moon ^a   Song, Byeong Wook ^a   Ha, Hye Yeong ^a   Huh, Yong Joon ^a   Choi, In Geol ^b   Hwang, Dong Youn ^c   Song, Heesang ^d   Jang, Yangsoo ^a   Chung, Namsik ^a   Kim, Sung Hou ^e   Kim, Dong Wook ^a,f  

^a Yonsei University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c CHA University   (South Korea)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Stem Cell Research Laboratory   (South Korea)

Author keywords

Chemical modulation; Chondrocytes; Differentiation agonists; Dopaminergic neurons

Indexed keywords

PROTEIN KINASE; PROTEIN KINASE INHIBITOR;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; ANIMAL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; MOUSE; NERVE CELL; RAT;

RATTUS;

ANIMALS; CELL DIFFERENTIATION; CHONDROCYTES; EMBRYONIC STEM CELLS; MESENCHYMAL STEM CELLS; MICE; NEURONS; PROTEIN KINASE INHIBITORS; RATS;

EID: 44949240499     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0802825105     Document Type: Article

References (15)

1. Jaiswal RK, et al. (2000) Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645-9652.
2. Castelo-Branco G, Rawal N, Arenas E (2004) GSK-3β inhibition/β-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J Cell Sci 117:5731-5737.
3. Hu X, Jin L, Feng L (2004) Erk1/2 but not PI3K pathway is required for neurotrophin 3-induced oligodendrocyte differentiation of postnatal neural stem cells. J Neurochem 90:1339-1347.
4. Koyanagi M, et al. (2005) Noncanonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J Biol Chem 280:16838-16842.
5. Ding S, et al. (2003) Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci USA 100:7632-7637.
6. Manning G, et al. (2002) The protein kinase complement of the human genome. Science 298:1912-1934.
7. Pittenger MF, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
8. Leemhuis J, Boutillier S, Schmidt G, Meyer DK (2002) The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho kinase. J Pharmacol Exp Ther 300:1000-1007.
9. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
10. Kawasaki H, et al. (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279.
11. Combest WL, Bloom TJ, Gilbert LI (1998) Polyamines differentially inhibit cyclic AMP-dependent protein kinase-mediated phosphorylation in the brain of the tobacco hornworm, Manduca sexta. J Neurochem 51:1581-1591.
12. Kawasaki H, et al. (2000) Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28:31-40.
13. Kim DW, et al. (2006) Stromal cell-derived inducing activity, Nurr1, and signaling molecules synergistically induce dopaminergic neurons from mouse embryonic stem cells. Stem Cells 24:557-567.
14. Ikenoya M, et al. (2002) Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor. J Neurochem 81:9-16.
15. Sasaki Y, Suzuki M, Hidaka H (2002) The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]- homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol Ther 93:225-232.